Literature DB >> 19507145

Morphological studies on machined implants of commercially pure titanium and titanium alloy (Ti6Al4V) in the rabbit.

Anders Palmquist1, Fredrik Lindberg, Lena Emanuelsson, Rickard Brånemark, Håkan Engqvist, Peter Thomsen.   

Abstract

The aim of this study was to evaluate the bone response to commercially pure titanium grade I and titanium alloy grade V (90% Ti, 6% Al, and 4% V, depicted Ti6Al4V) after 8 weeks in rabbit tibia. Interference microscopy and scanning electron microscopy were used for surface analyses. Transmission electron microscopy (TEM) was used for evaluation of surface crystallinity and chemistry after preparation of ultrathin sections using focused ion beam (FIB) microscopy. Three different embedding resins commonly used for histological preparation were evaluated with respect to adaptation to a turned implant surface. Epoxy Agar 100 resin and acrylic Technovit 7200 resin showed low separation while acrylic LR White resin showed large separation at the interface. The retrieved specimens were embedded in acrylic Technovit 7200 resin after fixation and dehydration. The histological evaluation revealed osseointegration for both c.p. titanium grade I and Ti6Al4V alloy, but no quantitative differences in bone contact and bone area were detected. Because a separation of implant and tissue occurred in the interface between implant and bone embedded in acrylic Technovit 7200 resin, additional factors related to implant surface properties and technical procedures are likely to influence the possibilities to prepare ultrathin sections by FIB. (c) 2009 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19507145     DOI: 10.1002/jbm.b.31404

Source DB:  PubMed          Journal:  J Biomed Mater Res B Appl Biomater        ISSN: 1552-4973            Impact factor:   3.368


  8 in total

Review 1.  Titanium oral implants: surface characteristics, interface biology and clinical outcome.

Authors:  Anders Palmquist; Omar M Omar; Marco Esposito; Jukka Lausmaa; Peter Thomsen
Journal:  J R Soc Interface       Date:  2010-06-30       Impact factor: 4.118

2.  Imaging, virtual planning, design, and production of patient-specific implants and clinical validation in craniomaxillofacial surgery.

Authors:  Per Dérand; Lars-Erik Rännar; Jan-M Hirsch
Journal:  Craniomaxillofac Trauma Reconstr       Date:  2012-09

3.  Free-form-fabricated commercially pure Ti and Ti6Al4V porous scaffolds support the growth of human embryonic stem cell-derived mesodermal progenitors.

Authors:  G M de Peppo; A Palmquist; P Borchardt; M Lennerås; J Hyllner; A Snis; J Lausmaa; P Thomsen; C Karlsson
Journal:  ScientificWorldJournal       Date:  2012-01-04

4.  Retrieved bone-anchored percutaneous amputation prosthesis showing maintained osseointegration after 11 years-a case report.

Authors:  Anders Palmquist; Sara H Windahl; Birgitta Norlindh; Rickard Brånemark; Peter Thomsen
Journal:  Acta Orthop       Date:  2014-05-05       Impact factor: 3.717

Review 5.  A multiscale analytical approach to evaluate osseointegration.

Authors:  Anders Palmquist
Journal:  J Mater Sci Mater Med       Date:  2018-05-07       Impact factor: 3.896

6.  Investigating the biological response of human mesenchymal stem cells to titanium surfaces.

Authors:  Matthew J German; Charles Osei-Bempong; Callie A Knuth; David J Deehan; Rachel A Oldershaw
Journal:  J Orthop Surg Res       Date:  2014-12-12       Impact factor: 2.359

7.  Laser-Modified Surface Enhances Osseointegration and Biomechanical Anchorage of Commercially Pure Titanium Implants for Bone-Anchored Hearing Systems.

Authors:  Furqan A Shah; Martin L Johansson; Omar Omar; Hanna Simonsson; Anders Palmquist; Peter Thomsen
Journal:  PLoS One       Date:  2016-06-14       Impact factor: 3.240

8.  The Use of ESEM-EDX as an Innovative Tool to Analyze the Mineral Structure of Peri-Implant Human Bone.

Authors:  Carlo Prati; Fausto Zamparini; Daniele Botticelli; Mauro Ferri; Daichi Yonezawa; Adriano Piattelli; Maria Giovanna Gandolfi
Journal:  Materials (Basel)       Date:  2020-04-03       Impact factor: 3.623

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.